Diabetes Mellitus

Also known as: Diabetes · DM · Sugar disease (colloquial) · Diyabetis / asukal sa dugo (Filipino colloquial usages) · Historically, type-specific terms: juvenile-onset and adult-onset diabetes; insulin-dependent (IDDM) and non-insulin-dependent diabetes mellitus (NIDDM)

Medicine

Definition

Diabetes mellitus is a heterogeneous group of chronic endocrine and metabolic disorders characterized by sustained hyperglycemia — persistently elevated blood glucose — resulting from defects in insulin secretion, insulin action, or both. Insulin, produced by the beta cells of the pancreatic islets of Langerhans, is the principal hormone regulating glucose uptake; when it is absent, insufficient, or ineffective, glucose accumulates in the blood while cells are starved of fuel. Chronic hyperglycemia damages blood vessels and nerves, producing the classic long-term complications of diabetes: retinopathy (leading cause of preventable blindness), nephropathy (a leading cause of end-stage renal disease), neuropathy, and accelerated cardiovascular disease. The MeSH medical vocabulary defines diabetes mellitus simply as “a heterogeneous group of disorders characterized by hyperglycemia and glucose intolerance.” (Wikipedia, MeSH)

The principal forms are type 1 diabetes (autoimmune destruction of beta cells, requiring insulin for survival), type 2 diabetes (insulin resistance with progressive beta-cell failure, the most common form), gestational diabetes (first recognized in pregnancy), and a set of other specific types — monogenic forms such as maturity-onset diabetes of the young (MODY), and secondary diabetes due to pancreatic disease, endocrinopathies, or drugs. Diabetes mellitus is distinct from diabetes insipidus, an unrelated water-balance disorder sharing only the historical word “diabetes” (excessive urination). (Wikipedia)

Identities

Source Type	Identity
Wikipedia	Diabetes (diabetes mellitus)
Wikidata	diabetes mellitus (Q12136)
DBpedia	N/A
ProductOntology	N/A
Wiktionary	diabetes
Library of Congress Subject Headings (LCSH)	Diabetes
MeSH	Diabetes Mellitus (D003920)
NCBI Taxonomy	N/A
AGROVOC	N/A
Google Scholar	“diabetes mellitus” classification diagnosis management
ConceptNet	N/A
OpenCyc	N/A

Also Known As

Diabetes
DM
Sugar disease (colloquial)
Diyabetis / asukal sa dugo (Filipino colloquial usages)
Historically, type-specific terms: juvenile-onset and adult-onset diabetes; insulin-dependent (IDDM) and non-insulin-dependent diabetes mellitus (NIDDM)

Examples and Analogies

The lock-and-key analogy: Insulin is a key and body cells have locks (insulin receptors). In type 1 diabetes the key factory has burned down — no keys are made, so glucose cannot enter cells. In type 2 diabetes the locks are rusted (insulin resistance); the factory first makes extra keys to compensate, but eventually wears out. Same blocked door, different broken parts — which is why the two diseases share a name but not a treatment.
The overflow analogy: The bloodstream is a storage tank with a regulated outlet. In diabetes the outlet (insulin-mediated glucose uptake) is blocked, so the tank overflows — glucose spills into the urine (causing the classic symptoms of excessive urination and thirst) while tissues downstream run dry.
Verified epidemiology:
Global: the World Health Organization reports that the number of people living with diabetes rose from 200 million in 1990 to 830 million in 2022; the International Diabetes Federation estimated 536.6 million adults (20–79) in 2021, projected to 783.2 million by 2045 (WHO, IDF Atlas)
Philippines: the IDF lists Philippine adult diabetes prevalence at 7.5%, totalling approximately 4.73 million adults with diabetes [(verify)] for the edition year of the cited figure (IDF — Philippines).

Usage Scenarios

1. Clinical Diagnosis

Diabetes is diagnosed by measuring glucose or glycated hemoglobin: fasting plasma glucose ≥ 126 mg/dL, 2-hour oral glucose tolerance test ≥ 200 mg/dL, HbA1c ≥ 6.5%, or random plasma glucose ≥ 200 mg/dL with classic symptoms, confirmed by repeat testing. The same thresholds, applied in Philippine practice per national guideline adoption of international criteria, define the boundary between normal glucose tolerance, prediabetes, and diabetes. (Wikipedia)

2. Classification for Treatment Selection

Physicians classify the type of diabetes to select therapy: type 1 requires lifelong insulin replacement; type 2 is managed stepwise with lifestyle change and oral or injectable agents (metformin first-line, with GLP-1 receptor agonists and SGLT2 inhibitors for selected patients); gestational diabetes is managed with diet and, when needed, insulin, because of fetal safety considerations.

3. Complication Screening and Risk Management

Standard care schedules periodic retinal examination, urine albumin and renal-function testing, foot examination, and aggressive cardiovascular risk-factor control (blood pressure, lipids, smoking cessation) — the interventions that convert diabetes from an acute crisis into a manageable chronic condition.

4. Public-Health Surveillance and Programs

National health systems, including the Philippine Department of Health, incorporate diabetes into noncommunicable-disease programs: screening campaigns, essential-medicine lists, PhilHealth coverage packages, and lifestyle-prevention messaging targeted at the overweight, sedentary, and family-history groups at highest risk. (WHO)

5. Acute Emergency Recognition

Patients and caregivers are taught to recognize hyperglycemic emergencies — diabetic ketoacidosis (predominantly type 1) and hyperosmolar hyperglycemic state (predominantly type 2) — and hypoglycemia from treatment mismatch, the principal preventable acute harms of the disease and its therapy.

Strategies

Prevention through lifestyle: For type 2 diabetes, structured lifestyle change — modest weight reduction, regular physical activity, and dietary modification — demonstrably delays or prevents progression from prediabetes to diabetes, the basis of population-level prevention policy. (WHO)
Glycemic targets individualized by risk: Treatment intensity is calibrated to age, complications, and hypoglycemia risk rather than applied uniformly — tight control benefits younger newly diagnosed patients most, while de-intensification is appropriate in frail elderly patients.
Cardiometabolic drug selection: Modern type 2 therapy selects among drug classes by comorbidity — GLP-1 receptor agonists and SGLT2 inhibitors for cardiovascular and renal benefit beyond glucose lowering — rather than by glucose efficacy alone.
Structured self-management education: Teaching patients self-monitoring, medication adherence, sick-day rules, and foot care is a core, cost-effective strategy across all diabetes types.
Screening the high-risk: Targeted screening of adults with obesity, family history, hypertension, or history of gestational diabetes identifies disease before complications begin, and is standard in Philippine primary-care protocols. (IDF — Philippines)

Security and Safety Measures

Medication safety systems: Insulin and sulfonylurea stewardship — correct dosing, timing, and storage of insulin — prevents iatrogenic hypoglycemia, the most common acute treatment harm.
Surgical and perioperative protocols: Elective surgery in diabetes requires pre-procedure glycemic assessment and perioperative glucose management to reduce infection and wound-healing complications.
Foot-protection protocols: Daily foot inspection, appropriate footwear, and prompt treatment of minor wounds prevent progression to ulceration and amputation, a major diabetes-related burden in lower-income settings.
Anti-counterfeit vigilance: High-demand diabetes medicines, including insulin pens and injectable GLP-1 agonists, are targets of counterfeiting; regulators such as the Philippine FDA issue advisories against unregistered sources.
Population screening quality control: Public screening programs use validated instruments and confirmatory testing to avoid both over- and under-diagnosis at the population scale.

Historical Context

Diabetes is one of the oldest described diseases: Egyptian papyri (c. 1550 BCE) describe a condition of profuse sweet urine, and Greek physician Areteus of Cappadocia (2nd century CE) named it diabetes, “a siphon,” for its relentless urination. The distinction between the two main clinical forms crystallized in the 19th century, and the modern era began in 1921, when Banting and Best isolated insulin, converting type 1 diabetes from a uniformly fatal disease into a survivable chronic condition. The 1979–1980 National Diabetes Data Group and WHO classifications formalized today’s terminology — type 1, type 2, gestational, and other types — replacing the older age-based labels “juvenile-onset” and “adult-onset.” (Wikipedia)

The contemporary history of diabetes is an epidemiological one: as populations urbanize, eat more energy-dense food, and move less, type 2 diabetes has risen from a rarity to one of the world’s leading causes of death and disability. WHO estimates that diabetes prevalence roughly quadrupled between 1990 and 2022, to 830 million people, with more than half of affected adults not taking medication — a treatment gap concentrated in low- and middle-income countries, including the Philippines, where the IDF counts roughly 4.7 million adults with diabetes. This trajectory has made diabetes prevention and control a flagship noncommunicable-disease priority of the WHO and of national programs. (WHO, IDF — Philippines)

Challenges and Controversies

The Silent Epidemic and Underdiagnosis

Diabetes is asymptomatic for years; the WHO notes that a large share of people with diabetes — and in Philippine estimates, a substantial undiagnosed fraction — are unaware of their condition, presenting first with complications. Expanding affordable screening without overwhelming primary care is an unresolved health-systems problem. (WHO, IDF — Philippines)

Access to Insulin and Newer Medicines

A century after its discovery, insulin remains inaccessible or unaffordable to many patients in low- and middle-income countries; newer agents such as GLP-1 receptor agonists are expensive and in global shortage of supply, raising equity questions as they outperform older drugs for selected outcomes.

Defining Diagnostic Thresholds

The boundaries between normal glucose tolerance, prediabetes, and diabetes are statistical conventions; HbA1c-based diagnosis performs differently across ethnic groups and in conditions like anemia, and debates continue over the population-level consequences of reclassifying millions as patients through threshold changes.

Weight-Centric Stigma versus Care

Because type 2 diabetes is strongly associated with obesity, public discourse often frames it as a consequence of personal failing. Clinical and public-health bodies counter that the disease is driven by genetics, food environments, and social determinants, and that stigma worsens outcomes by discouraging care-seeking — a genuine tension in health communication.

Philippine Data Gaps

Prevalence figures for the Philippines vary across DOH, IDF, and academic surveys because of differing methodologies, sampling, and diagnostic criteria; precise national figures — and their projections — should be cited with the source and year attached rather than as fixed facts [(verify)] for the most recent national survey.